Beckley Psytech Pitch Deck

Beckley Psytech is at the forefront of the psychedelic medicine industry, specializing in the development and exploration of transformative therapies. As a pioneering psychedelic medicine company, our primary focus lies in creating a robust drug pipeline consisting of psychedelic medicines. We firmly believe that these medicines hold immense commercial potential in addressing unmet clinical needs. Through our groundbreaking research and development efforts, we aim to unlock the therapeutic power of psychedelics and revolutionize the treatment landscape. At Beckley Psytech, we are committed to pushing the boundaries of medicine to provide innovative solutions for those in need.

$186M • 2020 • Series A